A case of natalizumab-associated progressive multifocal leukoencephalopathy with repeated negative CSF JCV testing

International Journal of Neuroscience

Volumn 123, Issue 5, 2013, Pages 353-357

  Mazda, Monica E ^a   Brosch, Jared R ^a   Wiens, Andrea L ^a   Bonnin, José M ^a   Kamer, Aaron P ^a   Mattson, David H ^a   Snook, Riley J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain biopsy; Cerebrospinal fluid; JC virus; Natalizumab; Progressive multifocal leukoencephalopathy

Indexed keywords

AMITRIPTYLINE; GLATIRAMER; INSULIN; INTERFERON BETA SERINE; LEVOTHYROXINE; NATALIZUMAB; STEROID;

AGED; ARTICLE; ATAXIA; ATAXIC APHASIA; BRAIN BIOPSY; CASE REPORT; DIABETIC NEUROPATHY; DIPLOPIA; DRUG WITHDRAWAL; FACIAL NERVE PARALYSIS; FEMALE; GENERAL CONDITION DETERIORATION; HAND PARESTHESIA; HEMIPARESIS; HUMAN; HUMAN TISSUE; HYPOTHYROIDISM; IMMOBILIZATION; IMMUNOHISTOCHEMISTRY; LUMBAR PUNCTURE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REPEAT PROCEDURE; SPEECH DISORDER; TREATMENT DURATION; WALKER;

AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; BIOLOGICAL MARKERS; FEMALE; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL;

EID: 84876400264     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2012.760561     Document Type: Article

References (21)

1. Van Assche G, Van Ranst M, Sciot R, et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 2005;353:362-8.
2. Kleinschmidt-DeMasters B, Tyler K. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 2005;353:369-74.
3. Langer-Gould A, Atlas S, Green A, et al. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 2005;353:375-81.
4. Kappos L, Bates D, Edan G, et al. Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring. Lancet Neurol 2011;10:745-58.
5. Berger J,Major E. Progressive multifocal leukoencephalopathy. Semin Neurol 1999;19:193-200.
6. Egli A, Infanti L,Dumoulin A, et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 2009;199(15 March):837-46.
7. Cinque P, Koralnik I, Gerevini S, et al. Progressive multifocal leukoencephalopathy in HIV-1 infection. Lancet Infect Dis 2009;9(October):625- 36.
8. Reid C, Li H, Sur G, et al. Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients. J Infect Dis 2011;204(15 July):237-44.
9. Astrom K-E, Mancall EL, Richardson E, Jr. Progressive multifocal leuko-encephalopathy a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain. 1958;81:93-111.
10. Keene D, Legare C, Taylor E, et al. Monoclonal antibodies and progressive multifocal leukoencephalopathy. Can J Neurol Sci 2011;38:565-71.
11. Major E. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu Rev Med 2010;61:35-47.
12. Bloomgren G, Richman S, Hotermans C, et al. Risk of natalizumab- associated progressive multifocal leukoencephalopathy. N Engl J Med 2012;366:1870-80.
13. Anzai Y, Jhaveri MD, Anderson JS. Pathology-based diagnoses: infectious and demyelinating disease. In: Osborn, A, Salzman, KL, Barkovich, J et al., eds. Diagnostic imaging: brain. 2nd ed. Altona, Manitoba, Canada: Friesens; 2009.
14. Linda H, von Heijne A, Major E, et al. Progressive multifocal leukoencephalopathy after natalizumab monotherapy. N Engl J Med 2009;361:1081-7.
15. Kuhle J, Gosert R, Buhler R, et al. Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS. Neurology 2011;2010-16.
16. Dumoulin A, Hirsch H. Reevaluating and optimizing polyomavirus BK and JC real-time PCR assays to detect rare sequence polymorphisms. J Clin Microbiol 2011;49: 1382-88.
17. Focus Diagnostics. Focus Diagnostics Catalog Search. Available from: http://www.focusdx.com/focus/1- reference laboratory/search frame.aspf=10. [last accessed 19 Jul 2012].
18. Franciotta D, Bestetti A, Bergamaschi R, et al. Failure to detect JC virus DNA in cerebrospinal fluid of multiple sclerosis patients. Mult Scler 2006;12:674-5.
19. Warnke C, Menge T, Hartung HP, et al. Natalizumab and progressive multifocal leukoencephalopathy. Arch Neurol 2010;67:923-30.
20. Wenning W, Haghikia A, Laubenberger J, et al. Treatment of progressive multiforcal leukoencephalopathy associated with natalizumab. N Engl J Med 2009;361:1075-80.
21. Schroder A, Lee DH, Hellwig K, et al. Successful management of natalizumab-associated pregressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis. Arch Neurol 2010;67: 1391-4.